Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, et al. Non-small cell lung cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(5):497–530.
Skronska-Wasek W, Gosens R, Konigshoff M, Baarsma HA. WNT receptor signalling in lung physiology and pathology. Pharmacol Ther. 2018;187:150–66.
Article CAS PubMed Google Scholar
Rim EY, Clevers H, Nusse R. The Wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem. 2022;91:571–98.
Article CAS PubMed Google Scholar
Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. 2014;106(1):djt356.
van der Wal T, van Amerongen R. Walking the tight wire between cell adhesion and WNT signalling: a balancing act for beta-catenin. Open Biol. 2020;10(12): 200267.
Article PubMed PubMed Central Google Scholar
Lach RS, Qiu C, Kajbaf EZ, Baxter N, Han D, Wang A, Lock H, Chirikian O, Pruitt B, Wilson MZ. Nucleation of the destruction complex on the centrosome accelerates degradation of beta-catenin and regulates Wnt signal transmission. Proc Natl Acad Sci U S A. 2022;119(36): e2204688119.
Article CAS PubMed PubMed Central Google Scholar
Cantoria MJ, Alizadeh E, Ravi J, Varghese RP, Bunnag N, Pond KW, Kettenbach AN, Ahmed Y, Paek AL, Tyson JJ, et al. Feedback in the beta-catenin destruction complex imparts bistability and cellular memory. Proc Natl Acad Sci U S A. 2023;120(2): e2208787120.
Article CAS PubMed PubMed Central Google Scholar
Vamadevan V, Chaudhary N, Maddika S. Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. J Cell Sci. 2022;135(24):jcs260284.
Article CAS PubMed Google Scholar
Kang K, Shi Q, Wang X, Chen YG. Dishevelled phase separation promotes Wnt signalosome assembly and destruction complex disassembly. J Cell Biol. 2022;221(12): e202205069.
Article CAS PubMed PubMed Central Google Scholar
Liu DX, Hao SL, Yang WX. Crosstalk between beta-CATENIN-mediated cell adhesion and the WNT signaling pathway. DNA Cell Biol. 2023;42(1):1–13.
Gonzalez-Mariscal L, Miranda J, Gallego-Gutierrez H, Cano-Cortina M, Amaya E. Relationship between apical junction proteins, gene expression and cancer. Biochim Biophys Acta Biomembr. 2020;1862(9): 183278.
Article CAS PubMed Google Scholar
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341–52.
Article PubMed PubMed Central Google Scholar
Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2(2): a002915.
Article PubMed PubMed Central Google Scholar
Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–22.
Article CAS PubMed Google Scholar
Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA. Long noncoding RNAs in cancer metastasis. Nat Rev Cancer. 2021;21(7):446–60.
Article CAS PubMed PubMed Central Google Scholar
Chen L, Shan G. CircRNA in cancer: fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49–57.
Article CAS PubMed Google Scholar
Licchesi JD, Westra WH, Hooker CM, Machida EO, Baylin SB, Herman JG. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis. 2008;29(5):895–904.
Article CAS PubMed PubMed Central Google Scholar
Li HJ, Ke FY, Lin CC, Lu MY, Kuo YH, Wang YP, Liang KH, Lin SC, Chang YH, Chen HY, et al. ENO1 promotes lung cancer metastasis via HGFR and WNT signaling-driven epithelial-to-mesenchymal transition. Cancer Res. 2021;81(15):4094–109.
Article CAS PubMed Google Scholar
Guan S, Chen X, Chen Y, Xie W, Liang H, Zhu X, Yang Y, Fang W, Huang Y, Zhao H, et al. FOXM1 variant contributes to gefitinib resistance via activating Wnt/beta-catenin signal pathway in patients with non-small cell lung cancer. Clin Cancer Res. 2022;28(17):3770–84.
Article CAS PubMed Google Scholar
Han X, Jiang H, Qi J, Li J, Yang J, Tian Y, Li W, Jing Q, Wang C. Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma. Cell Death Dis. 2020;11(11):999.
Article CAS PubMed PubMed Central Google Scholar
Yao Y, Zhou Y, Hua Q. circRNA hsa_circ_0018414 inhibits the progression of LUAD by sponging miR-6807-3p and upregulating DKK1. Mol Ther Nucleic Acids. 2021;23:783–96.
Article CAS PubMed PubMed Central Google Scholar
Li Y, Sheng H, Ma F, Wu Q, Huang J, Chen Q, Sheng L, Zhu X, Zhu X, Xu M. RNA m(6)A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling. Cell Death Dis. 2021;12(5):479.
Article CAS PubMed PubMed Central Google Scholar
Sankar K, Gadgeel SM, Qin A. Molecular therapeutic targets in non-small cell lung cancer. Expert Rev Anticancer Ther. 2020;20(8):647–61.
Article CAS PubMed Google Scholar
Liu WJ, Du Y, Wen R, Yang M, Xu J. Drug resistance to targeted therapeutic strategies in non-small cell lung cancer. Pharmacol Ther. 2020;206: 107438.
Article CAS PubMed Google Scholar
Xue W, Cai L, Li S, Hou Y, Wang YD, Yang D, Xia Y, Nie X. WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice. Discov Oncol. 2023;14(1):136.
Article CAS PubMed PubMed Central Google Scholar
Sumitomo R, Huang CL, Ando H, Ishida T, Cho H, Date H. Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non-small cell lung cancer. Oncol Rep. 2022;48(5):189.
Article CAS PubMed PubMed Central Google Scholar
Xu J, Lv W, Hu Y, Wang L, Wang Y, Cao J, Hu J. Wnt3a expression is associated with epithelial-mesenchymal transition and impacts prognosis of lung adenocarcinoma patients. J Cancer. 2017;8(13):2523–31.
Article PubMed PubMed Central Google Scholar
Zhou HM, Zhao LM. Wnt signaling pathway-derived score for predicting therapeutic resistance and tumor microenvironment in lung adenocarcinoma. Front Pharmacol. 2022;13:1091018.
留言 (0)